Nomura Holdings Inc and Keio University are investing in a startup that is seeking to revolutionize how smokers quit the habit.
CureApp Inc, which develops mobile applications to treat ailments including tobacco addiction, received ¥380 million (US$3.4 million) this month from investors, including Nomura and Keio’s venture-capital partnership, the startup’s founder and chief executive officer Kohta Satake said in an interview.
An SBI Holdings Inc unit also contributed, and CureApp will use the funds to develop products and expand in the US, he said.
The venture’s success hinges on whether the anti-smoking app receives government permission for use as a treatment that’s eligible for coverage under Japan’s health-insurance program.
If it is approved, doctors will be able to prescribe the software, which provides users with real-time feedback on their telephones to resist the urge to smoke.
Japanese authorities revised the pharmaceutical law in 2014 to allow mobile apps to be recognized as medical devices, though none have achieved that designation yet, according to Satake.
CureApp’s product is currently being trialed and Satake, 34, a physician specializing in respiratory medicine, expects it to be approved by 2019.
“The company is very popular among investors and there was stiff competition to provide funding,” said Kotaro Yamagishi, chief executive of Keio Innovation Initiative Inc, the partnership between the Tokyo-based university and Nomura.
“We expect the app to be authorized for use on the national insurance program and it will be a profitable business,” he said.
CureApp aims to go public in 2020, Satake said.
The startup plans to set up an office in California this year.
It is also seeking to develop apps for patients with fatty-liver disease, diabetes and depression, he added.
Smoking rates in Japan have been declining for years as people become deterred by the health risks, tighter regulations and increases in prices and taxes.
Fewer than a fifth of the adult population now smoke, down from almost half in 1966, according to a Japan Tobacco Inc survey.
About half a million smokers in Japan seek clinical treatment to quit each year, relying partly on brief, infrequent consultations with their doctor, according to Satake.
“Giving up smoking can be a lonely battle,” Satake said.
OpenAI has warned US lawmakers that its Chinese rival DeepSeek (深度求索) is using unfair and increasingly sophisticated methods to extract results from leading US artificial intelligence (AI) models to train the next generation of its breakthrough R1 chatbot, a memo reviewed by Bloomberg News showed. In the memo, sent on Thursday to the US House of Representatives Select Committee on China, OpenAI said that DeepSeek had used so-called distillation techniques as part of “ongoing efforts to free-ride on the capabilities developed by OpenAI and other US frontier labs.” The company said it had detected “new, obfuscated methods” designed to evade OpenAI’s defenses
NEW IMPORTS: Car dealer PG Union Corp said it would consider introducing US-made models such as the Jeep Grand Cherokee and Stellantis’ RAM 1500 to Taiwan Tesla Taiwan yesterday said that it does not plan to cut its car prices in the wake of Washington and Taipei signing the Agreement on Reciprocal Trade on Thursday to eliminate tariffs on US-made cars. On the other hand, Mercedes-Benz Taiwan said it is planning to lower the price of its five models imported from the US after the zero tariff comes into effect. Tesla in a statement said it has no plan to adjust the prices of the US-made Model 3, Model S and Model X as tariffs are not the only factor the automaker uses to determine pricing policies. Tesla said
China’s top chipmaker has warned that breakaway spending on artificial intelligence (AI) chips is bringing forward years of future demand, raising the risk that some data centers could sit idle. “Companies would love to build 10 years’ worth of data center capacity within one or two years,” Semiconductor Manufacturing International Corp (SMIC, 中芯) cochief executive officer Zhao Haijun (趙海軍) said yesterday on a call with analysts. “As for what exactly these data centers will do, that hasn’t been fully thought through.” Moody’s Ratings projects that AI-related infrastructure investment would exceed US$3 trillion over the next five years, as developers pour eye-watering sums
Australian singer Kylie Minogue says “nothing compares” to performing live, but becoming an international wine magnate in under six years has been quite a thrill for the Spinning Around star. Minogue launched her first own-label wine in 2020 in partnership with celebrity drinks expert Paul Schaafsma, starting with a basic rose but quickly expanding to include sparkling, no-alcohol and premium rose offerings. The actress and singer has since wracked up sales of around 25 million bottles, with her carefully branded products pitched at low-to mid-range prices in dozens of countries. Britain, Australia and the United States are the biggest markets. “Nothing compares to performing